However, an exploratory analysis of a pre-specified subgroup of patients with TP53 wild-type endometrial cancer showed a promising efficacy signal. In the SIENDO study, 263 patients were randomly ...
- Findings to be Presented at the 2025 Joint Congress of the European Society for Paediatric Endocrinology and the European Society of Endocrinology Overproduction of androstenedione, a key adrenal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results